Surprising Enhancement of Fibrosis by Tubule-Specific Deletion of the TGF-β Receptor: A New Twist on an Old Paradigm
Author(s) -
David P. Basile,
Purvi Mehrotra
Publication year - 2017
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2017080947
Subject(s) - fibrosis , transforming growth factor , extracellular matrix , myofibroblast , growth factor , cancer research , medicine , pathology , microbiology and biotechnology , biology , receptor
Tubulointerstitial fibrosis has long been recognized as the most significant structural lesion associated with the development and progression of CKD. Since the pioneering work of Border and Ruoslahti,[1][1] the pleiotropic factor TGF- β has assumed a central role in the genesis of
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom